Over the years, a lot of research has been carried out in the field of breast diseases -benign and malignant - spanning from diagnosis to treatment. It is important for all clinicians to keep up with this vast reservoir of knowledge, understand it and translate it into guidelines that are applicable in day-to-day clinical practice. This is called Evidence-Based Medicine.
At Kokilaben Hospital, we follow the model of Evidence-Based Medicine so that our patients can receive the highest level of care in surgery, chemotherapy or radiotherapy that is prevalent in the world. For instance, in the field of breast cancer management, the next step of individualising treatment for each and every patient using new molecular predictors of recurrence, by techniques, such as microarrays and Reverse Transcription-Polymerase Chain Reaction (RT-PCR) is already a part of treatment plan at Kokilaben Hospital. Such advances in technology have allowed us to quantify the risk of relapse for an individual patient and tailor the therapy accurately, like avoiding chemotherapy in patients who are at low risk of relapse as estimated using these new assays. Such advances in management are practiced on a regular basis in the CBCU at Kokilaben Hospital.